Prostate Cancer - Results from #26020

An overview of sipuleucel-T: Autologous cellular immunotherapy for prostate cancer - Abstract April 27, 2012

Smokers: At risk for prostate cancer but unlikely to screen - Abstract April 27, 2012

Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer - Abstract April 26, 2012

Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: The Australian perspective - Abstract April 26, 2012

Intrusion, avoidance, and daily negative affect among couples coping with prostate cancer: A dyadic investigation - Abstract April 26, 2012

Genome-wide two-locus epistasis scans in prostate cancer using two European populations - Abstract April 26, 2012

Computer-aided quantitative bone scan assessment of prostate cancer treatment response - Abstract April 25, 2012

In Vivo (31) P MR spectroscopic imaging of the human prostate at 7 T: Safety and feasibility - Abstract April 25, 2012

Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy - Abstract April 25, 2012

Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue - Abstract April 25, 2012

Dose-escalated simultaneous integrated-boost treatment of prostate cancer patients via helical tomotherapy - Abstract April 25, 2012

Radical prostatectomy in very high-risk localized prostate cancer: Long-term outcomes and outcome predictors - Abstract April 25, 2012

An evaluation of the contouring abilities of medical dosimetry students for the anatomy of a prostate cancer patient - Abstract April 25, 2012

Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? - Abstract April 24, 2012

Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer - Abstract April 24, 2012

The prostate cancer bone marrow niche: More than just 'fertile soil' - Abstract April 24, 2012

Formalized prediction of clinically significant prostate cancer: Is it possible? - Abstract April 24, 2012

Resection of metastases from prostate cancer - Abstract April 23, 2012

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort - Abstract April 23, 2012

Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomy - Abstract April 23, 2012

Page 1302 of 1437